Neoteryx, LLC now part of Trajan Scientific and Medical

Neoteryx, LLC now part of Trajan Scientific and Medical

January 06, 2022

Many of us would say that 2021 was a challenging year.  For Trajan though it was marked by a successful IPO on the ASX in June, followed by several acquisitions and equity investments.  As well as finalizing the previously announced acquisition of LEAP PAL Parts LLC in the last days of the year. On December 30th Trajan also completed the acquisition of Neoteryx, LLC (“Neoteryx”), a global leader in blood microsampling devices based in Torrance, California, USA, (www.neoteryx.com).

Neoteryx’s leading product line, Mitra®, is based on patented VAMS® (Volumetric Absorptive Micro-sampling) technology and is highly complementary to our own hemaPEN®.

Stephen Tomisich, Trajan founder and CEO stated. “This acquisition will mark the moment that Trajan changed gear in driving the global commercialization and adoption of microsampling at scale. Remote sampling is an essential element in progressing personalized, preventative and data-based healthcare. We are building our device portfolio and the marriage with Neoteryx, brings together the hemaPEN® format, Mitra®, VAMS® and soon our micro-biopsy device for skin sampling.”

“Importantly we are also building the tools around the entire workflow, from consumer portals to laboratory automation, through to the laboratory function itself. As a result of this transaction, we expect to see a meaningful acceleration of the microsampling portfolio’s contribution to growth over the next 3-5 years.”

Bringing Neoteryx under the Trajan banner isn’t just about the device or products it is also about the global Neoteryx team. It’s a dynamic leadership group based in the USA, UK and Europe with a combined 50 years of experience in microsampling commercialization, and strong backgrounds in chromatography and sample preparation.

Stephen Tomisich will step into an acting CEO role for Neoteryx. Mr Fasha Mahjoor, Neoteryx’s Founder and CEO, will step down from his executive role, however, as a result of this transaction he will become a Trajan Group Holdings Limited (ASX: TRJ) shareholder.

The Trajan team is looking forward to working with their new colleagues and continuing to pursue science-based and decentralized health care systems to deliver better health outcomes for society.




Also in News

Trajan completes the acquisition of LEAP PAL Parts and Consumables, LLC
Trajan completes the acquisition of LEAP PAL Parts and Consumables, LLC

January 06, 2022

Trajan Scientific and Medical acquires LEAP PAL Parts and Consumables, LLC (“LPP”) based in Raleigh North Carolina USA.

Read More

Trajan acquires Axel Semrau, a laboratory automation, chromatography, and software business
Trajan acquires Axel Semrau, a laboratory automation, chromatography, and software business

November 24, 2021

Trajan Scientific and Medical has finalized the acquisition of the latest addition to their portfolio, Axel Semrau GmbH & Co expanding its capabilities in the automation, chromatography, and software business.

Read More

Trajan completes ISO 9001 recertification
Trajan completes ISO 9001 recertification

July 14, 2021

Trajan Scientific and Medical has successfully completed a 3-year ISO 9001:2015 recertification at our Ringwood global headquarters this week, cementing the importance that we place over quality management and continuous improvement for ourselves and all stakeholders.

Read More